Tag: asco conference 2020
Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Versus bevacizumab (BEV) + mFOLFOX6
Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Versus bevacizumab (BEV) + mFOLFOX6
0
0
0
8 Jul, 10:01 AM
ASCO Conference Abstracts - Major Data Readouts
ASCO Conference Abstracts - Major Data Readouts
0
0
0
6 Jul, 11:44 AM
